Skin Cancer

Skin cancer is the most common type of cancer in the U.S. It occurs in more than a million people each year, including many older people. There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Of the three, melanoma is the most serious. Skin cancer occurs when abnormal cells form and multiply in an uncontrolled way in the epidermis, or abnormal cells from the epidermis invade the dermis of the skin. Basal cell carcinoma, squamous cell carcinoma, and melanoma are skin cancers that are named for the epidermal cells from which they develop.
What is Skin Cancer?

Skin cancer is the most common type of cancer among light skinned individuals. It is the commonest cancer in the United States and in Australia. Each year, about one million people are diagnosed with this cancer. In 85 percent of these cases, the skin damage leading to the cancer occurs before an individual is 18.

Read More

Overview

Feature Articles

Latest Skin Cancer News and Research

Research explores how photo-oxidized sterols kill melanoma cells

Research explores how photo-oxidized sterols kill melanoma cells

Empa scientists create innovative hydrogel for simulating the human skin

Empa scientists create innovative hydrogel for simulating the human skin

Blood test for tumor DNA may predict melanoma recurrence

Blood test for tumor DNA may predict melanoma recurrence

Boosting tumor-infiltrating lymphocyte therapy with the power of B cells

Boosting tumor-infiltrating lymphocyte therapy with the power of B cells

GSK3β identified as a driver of drug resistance in BRAF mutant melanoma

GSK3β identified as a driver of drug resistance in BRAF mutant melanoma

Protein linked to Parkinson's also found to drive melanoma growth

Protein linked to Parkinson's also found to drive melanoma growth

New 3D imaging technique enhances basal cell carcinoma diagnosis

New 3D imaging technique enhances basal cell carcinoma diagnosis

Blocking an enzyme to overcome immunotherapy resistance in melanoma patients

Blocking an enzyme to overcome immunotherapy resistance in melanoma patients

Enhancing skin cancer screening with 3D imaging technology

Enhancing skin cancer screening with 3D imaging technology

City of Hope researchers uncover the two-step process of tumor formation

City of Hope researchers uncover the two-step process of tumor formation

Melanoma cells use stealth strategy to survive targeted therapy

Melanoma cells use stealth strategy to survive targeted therapy

Yale scientists develop advanced CRISPR tool to study complex genetic interactions

Yale scientists develop advanced CRISPR tool to study complex genetic interactions

White wine vs. red wine: Which poses a greater cancer risk?

White wine vs. red wine: Which poses a greater cancer risk?

Targeting MARCO enhances cancer immunotherapy effectiveness

Targeting MARCO enhances cancer immunotherapy effectiveness

Examining skin cancer risk perceptions and reported sunburns among U.S. adults

Examining skin cancer risk perceptions and reported sunburns among U.S. adults

Targeted alpha therapy offers new hope for treating metastatic melanoma

Targeted alpha therapy offers new hope for treating metastatic melanoma

Environmental factors and genes play key role in cancer development

Environmental factors and genes play key role in cancer development

Study questions the health benefits of red wine over white wine

Study questions the health benefits of red wine over white wine

Study sheds new light on brain evolution

Study sheds new light on brain evolution

Innovative photodynamic therapy targets melanoma with light-activated dyes

Innovative photodynamic therapy targets melanoma with light-activated dyes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.